Boosting in the age of Omicron.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 37066867.
- Also identified by DOI 10.7554/eLife.87358 and PMC identifier 10110234.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A third dose of the inactivated vaccine CoronaVac fails to stimulate the production of neutralizing antibodies which target the Omicron variant.
Medical subject headings
- Antibodies, Neutralizing
- COVID-19 Vaccines